Publication | Closed Access

Polypharmacy is associated with functional decline in Alzheimer's disease and Lewy body dementia

Neurodegenerative DiseasesAlzheimer's DiseaseAgingDementiaVascular DementiaNeurologyNeuroscienceNeurodegenerationLewy Body DementiaAging-associated DiseaseMedicineRisk FactorsFunctional DeclineGeriatric NeurologyHealth Sciences